Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Entecavir Prophylaxis vs Preemptive Use in Gastric Cancer HBV Carriers
NCT02777801Phase 2Unknown
- Sponsor
- Sun Yat-sen University
- Start
- Jun 2015
- Primary completion
- Dec 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of entecavir in hepatitis B (HBV), sponsored by Sun Yat-sen University. Status: unknown.
02
Drugs
entecavir
03
Conditions
hepatitis B (HBV)
Beyond the preview
Go deeper on NCT02777801.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02777801.